Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year review.
Adam W BartlettMegan P CannDaniel K YeohAnne BernardAnne L RyanChristopher C BlythRishi S KotechaBrendan J McMullanAndrew S MooreGabrielle M HaeuslerJulia E ClarkPublished in: Pediatric blood & cancer (2018)
Non-Aspergillus molds and non-albicans Candida contributed substantially to pediatric IFI in our study, with high IFI prevalence in leukemia and allogeneic HSCT cohorts. Inclusion of IFIs outside of European Organization for Research and Treatment of Cancer criteria revealed an IFI burden that would go otherwise unrecognized in published reports.
Keyphrases
- risk factors
- candida albicans
- bone marrow
- stem cell transplantation
- papillary thyroid
- hematopoietic stem cell
- young adults
- acute myeloid leukemia
- cell wall
- randomized controlled trial
- childhood cancer
- emergency department
- systematic review
- biofilm formation
- intensive care unit
- low dose
- lymph node metastasis
- replacement therapy